Trending Topic

virus closeup, contagious pathogen. Monkey pox virus closeup, contagious pathogen, infectious zoonotic disease
7 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

A double-stranded DNA virus of the Orthopoxvirus family, mpox (formerly monkeypox), continues to infect people daily, following the 2022 global outbreak.1 Two clades (clade 1 and clade 2) have been identified, with the 2022 outbreak caused by a subclade of clade 2, referred to as clade 2b.2 Comparatively, clade 1 leads to a more severe disease state and greater […]

COVID-19

An Introduction to COVID-19

On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic. The impact on the medical community has been huge, not only on the front line of medical care but also for those navigating patient treatment during this unprecedented situation.

The touchINFECTIOUS DISEASES expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.

Our supporting partners do not constitute an endorsement of the content on this page.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Mark CompleteCompleted
BookmarkBookmarked

The World Vaccine Congress Washington 2025, 21-24 April 2025, delivered another landmark year, bringing together more than 4,000 global stakeholders from biotechnology, pharmaceuticals, government, academia and the broader global health ecosystem. The event reinforced its standing as an influential and collaborative forum in ...

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Infectious Diseases, where we continue our mission to deliver insightful, cutting-edge perspectives in infectious disease diagnosis and management. This issue offers an array of topics spanning diagnostics, service delivery innovations and preventive ...

Mark CompleteCompleted
BookmarkBookmarked

A recent study published in Science Advances highlights significant and unequal declines in life expectancy in India during the COVID-19 pandemic.

Developed by Touch
Coverage from: CROI Coverage

HIV vaccine development harnesses breakthroughs in structure-based antigen design, sequencing, and single-cell analysis to create potent vaccines. Prof. Barney Graham, Professor of Medicine, Microbiology, Chemistry and Immunology, Morehouse School of Medicine in Atlanta, Georgia, USA explores advances reported at CROI 2024, emphasizing advances in targeting antibody lineages and augmenting CD8+ T cell responses, and highlighting sustaining funding models for HIV research and it's imperativeness for addressing broader public health issues.

Developed by Touch
Coverage from: CROI Coverage

HIV vaccine development, emphasizing HIV, RSV, and coronavirus COVID-19 research is discussed by Prof. Barney Graham. This information is crucial for immunologists, virologists, and those in vaccine research. Learn from cross-disciplinary strategies. You, as healthcare professionals in these fields, need to grasp these insights for innovation. HIV, RSV, and coronavirus studies offer valuable lessons. Keep up with the latest in vaccine technology.

Developed by Touch
Coverage from: CROI Coverage

HIV diagnostic technologies are rapidly advancing, as Dr. Nitika Pai discussed, with self-tests and multiplex testing leading the way in accuracy and accessibility. The challenge remains in cost and strategic deployment. This field interests infectious disease specialists, clinical epidemiologists, and public health professionals. Stay informed on innovations like CRISPR and machine learning to enhance patient care. NAT (Nucleic Acid Test) costs and algorithmic bias in machine learning need attention for equitable access.

Developed by Touch
Coverage from: CROI Coverage

HIV diagnostics have transformed post-COVID, enhancing the acceptance and implementation of self-tests globally. Dr Nitika Pai, Division of Clinical Epidemiology, Experimental Medicine, Infectious Disease, McGill University, Montreal, Canada, discusses advancements in HIV diagnostics, especially self-testing, which has increased the acceptance and implementation of HIV self-tests globally.

67 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Watch experts in infectious diseases discuss the issue of vaccine inequity in COVID-19 vaccination in Africa and the Middle East.

32 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr Anna Blakney, Prof. Dr. med. Oliver Cornely, Prof. Ann R Falsey

Leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.

37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION
Dr Farhan Fazal, Dr Nada Melhem

Watch experts in infectious diseases discuss COVID-19 vaccination challenges and strategies for improving vaccine uptake in the Middle East.

40 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION
Dr Christina Obiero, Dr John Amuasi

Watch experts in infectious diseases discuss COVID-19 vaccination challenges and strategies for improving vaccine uptake in Africa.

59 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION
Dr Angus Thomson, Dr Amaya Gillespie, Dr Henry Kyobe Bosa

A series of expert panel discussions providing multiple perspectives on a selection of key topics and what the data may mean for clinical practice

Developed by Touch
Coverage from: ECCMID Coverage

Molnupiravir, an oral antiviral against SARS-CoV-2 was first granted emergency use authorisation in 2021 to reduce the risk of hospitalisation and death in mild to moderate COVID-19 with increased risk of developing severe disease. We were delighted to speak with Prof. ...

Developed by Touch
Coverage from: ECCMID Coverage

PANORAMIC (ISRCTN30448031) was a multicentre, open-label, randomized controlled trial investigating novel treatments for COVID-19 in the UK. We were delighted to speak with Prof. Chris Butler (University of Oxford, Oxford, UK) to discuss the PANORAMIC study results, and how these ...

Developed by Touch
Coverage from: ECCMID Coverage

The COVID-19 pandemic brought about the accelerated development of vaccinations to protect against variants of SARS-CoV-2, recently new targets of broad protection against potential future variants have been outlined and numerous vaccine candidates are in pre-clinical and clinical development. It ...

Developed by Touch
Coverage from: ECCMID Coverage

Molnupiravir is an oral antiviral medication that has shown to be effective in treating COVID-19. Nirmatrelvir/ritonavir is a combination of two drugs that have been granted emergency use authorization for the treatment of COVID-19. Dr Jon Salmanton-Garcia (University of ...

Load More...
Close Popup